
==== Front
J Neuroimmune Pharmacol
J Neuroimmune Pharmacol
Journal of Neuroimmune Pharmacology
1557-1890
1557-1904
Springer US New York

39312021
10149
10.1007/s11481-024-10149-3
Research
Targeting Toll-like Receptor 4/Nuclear Factor-κB and Nrf2/Heme Oxygenase-1 Crosstalk via Trimetazidine Alleviates Lipopolysaccharide-Induced Depressive-like Behaviors in Mice
Mohamed Sarah S. sarah.elsayed@pharma.cu.edu.eg

Rasheed Nora O. Abdel
Ibrahim Weam W.
Shiha Nesma A.
https://ror.org/03q21mh05 grid.7776.1 0000 0004 0639 9286 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El Aini St, Cairo, Egypt
23 9 2024
23 9 2024
2024
19 1 5018 5 2024
1 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Depression is a global psychiatric illness that imposes a substantial economic burden. Unfortunately, traditional antidepressants induce many side effects which limit patient compliance thus, exploring alternative therapies with fewer adverse effects became urgent. This study aimed to investigate the effect of trimetazidine (TMZ); a well-known anti-ischemic drug in lipopolysaccharide (LPS) mouse model of depression focusing on its ability to regulate toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) as well as nuclear factor erythroid 2 related factor 2 (Nrf2)/ heme oxygenase-1 (HO-1) signaling pathways. Male Swiss albino mice were injected with LPS (500 µg/kg, i.p) every other day alone or parallel with oral doses of either escitalopram (Esc) (10 mg/kg/day) or TMZ (20 mg/kg/day) for 14 days. Treatment with TMZ attenuated LPS-induced animals' despair with reduced immobility time inforced swimming test. TMZ also diminished LPS- induced neuro-inflammation via inhibition of TLR4/NF-κB pathway contrary to Nrf2/HO-1 cascade activation with consequent increase in reduced glutathione (GSH) and HO-1 levels whereas the pro-inflammatory cytokines; tumor necrosis factor-α (TNF-α) and interleukin (IL)-1β were evidently reduced. Besides, TMZ replenished brain serotonin levels via serotonin transporter (SERT) inhibition. Thus, TMZ hindered LPS-induced neuro-inflammation, oxidative stress, serotonin deficiency besides its anti-apoptotic effect which was reflected by decreased caspase-3 level. Neuroprotective effects of TMZ were confirmed by the histological photomicrographs which showed prominent neuronal survival. Here we showed that TMZ is an affluent nominee for depression management via targeting TLR4/NF-κB and Nrf2/HO-1 pathways. Future research addressing TMZ-antidepressant activity in humans is mandatory to enroll it as a novel therapeutic strategy for depression.

Graphical Abstract

Keywords

Lipopolysaccharide
Trimetazidine
Depression
Mice
NF-κB
Nrf2
Cairo UniversityOpen access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).

issue-copyright-statement© Springer Science+Business Media, LLC, part of Springer Nature 2024
==== Body
pmcIntroduction

Depression is a common disabling mental disorder that is estimated to affect 5% of adults across the world (World Health Organization 2023). It is characterized by a cluster of symptoms that includes low mood and energy, loss of interest and pleasure, sleeping and eating disturbances, cognitive impairment, and suicidal ideation (Maffioletti et al. 2020; Li et al. 2021). These symptoms are associated with structural and neurochemical changes in mesolimbic and corticolimbic neural circuits which regulate mood and behavior, including the prefrontal cortex (PFC), amygdala, nucleus accumbens, and hippocampus (Afridi and Suk 2021). Decreased gray matter density in the hippocampus, amygdala and PFC has been reported in patients with depression (Yu et al. 2023). Moreover, volumes of the whole brain and hippocampus of depressed patients were found to be lower than those of the control group (Li et al. 2021).

The monoamine hypothesis is a widely embraced theory, which suggests that depression is attributed to dysregulations of monoamine neurotransmitters such as serotonin, norepinephrine, and dopamine (Lee et al. 2010). However, over the years, several other pathophysiological mechanisms have been implicated in the disease pathogenesis including impaired neurogenesis and synaptic plasticity, depleted neurotrophic factors, neuroinflammation, and oxidative stress (Jazvinšćak Jembrek et al. 2023; Fang et al. 2023). Postmortem findings of reduced hippocampal size and volume implicates dysregulated hippocampal neurogenesis in major depressive disorder (MDD) pathogenesis (Fries et al. 2023). This is primarily caused by disturbance in metabolic levels of neurotrophic factors such as brain-derived neurotrophic factor (BDNF) (Kamran et al. 2022). The latter is known to play a critical role in neurogenesis, neuronal survival and differentiation, synaptic plasticity, neuroprotection, learning, memory and mood control (Correia and Vale 2024).

Numerous studies have reported a significant association between neuro-inflammation and depression (Maffioletti et al. 2020; Owen et al. 2001; Raison et al. 2006; Goldsmith et al. 2016). The core features of inflammatory responses such as increased pro-inflammatory cytokine levels and abnormal changes in oxidative stress parameters including malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione-S-transferase (GST) have been reported in blood and brain samples of patients with MDD (Zhuo et al. 2022). Neuroinflammation is implicated in the pathophysiology of depression by increasing the proinflammatory cytokines, activating the hypothalamic–pituitary–adrenal (HPA) axis, interfering with the synthesis and metabolism of monoamines, increasing the neuronal apoptosis, and impairing the neurogenesis and neuroplasticity (Evrensel et al. 2020; Kouba et al. 2024).

In accordance, several studies have demonstrated that administration of the bacterial endotoxin lipopolysaccharide (LPS) can cause depressive symptoms in rodents (Liu et al. 2016; Stupp et al. 2018; Zhang et al. 2019). LPS triggers immune responses by acting on toll-like receptor 4 (TLR4), a vital pattern recognition receptor (PRR) (Ciesielska et al. 2021; Nonoguchi et al. 2022). Upon binding to TLR4, LPS can activate nuclear factor-κB (NF-κB) which induces the production of inflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α), eventually promoting oxidative stress and decreasing the expression of BDNF (Wei et al. 2022; Taniguti et al. 2018).

Oxidative stress is a major contributor to the pathogenesis of various neurological diseases such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and depression (Correia et al. 2023; Pizzino et al. 2017). It results from the imbalance between the production of free radicals, particularly reactive oxygen species (ROS) and antioxidant defense systems (Correia et al. 2023). The increased ROS levels are known to damage biological macromolecules such as nucleic acids, proteins, and lipids resulting in cellular damage (Bian et al. 2020; Arioz et al. 2019). Nuclear factor erythroid 2 related factor 2 (Nrf2) is a key transcription factor that regulates cellular antioxidant responses (Bian et al. 2020). It activates antioxidant response element (ARE)-dependent gene expression of various antioxidant and cytoprotective proteins such as SOD-1, glutathione peroxidase (GPx), GST, and heme oxygenase-1 (HO-1) (Abou El-Ezz et al. 2018). The latter is an enzyme that possesses anti-inflammatory and antioxidant activities (Bian et al. 2020). Nrf2 inhibition is reportedly involved in the development of MDD. Indeed, decreased prefrontal cortex expression of Nrf2 has been documented in both MDD patients and experimental models of depression. On the other hand, compounds activating Nrf2 have shown considerable antidepressant effects in preclinical studies, suggesting that targeting Nrf2 could be a promising strategy to combat depression (Zuo et al. 2022).

Blood–brain barrier (BBB) is essential for maintenance of the central nervous system (CNS) homeostasis (Huang et al. 2021). It is formed by specialized endothelial cells that line the cerebral microvasculature and regulates the passage of molecules and cells between the blood and the brain (Gastfriend et al. 2018; Daneman and Prat 2015). Therefore, the BBB protects the brain from toxins, pathogens, inflammation, injury, and diseases (Daneman and Prat 2015). The integrity of the BBB is maintained mainly by tight junction proteins such as claudin-5, whose loss has been implicated in loosening of the BBB and increased permeability (Zhou et al. 2014; Menard et al. 2017). BBB disruption has been involved in the pathogenesis of different CNS diseases such as depression, epilepsy and schizophrenia (Ibrahim et al. 2022). Moreover, peripheral inflammation including LPS-induced inflammation is reported to disrupt the BBB via various pathways (Huang et al. 2021). Indeed, LPS reportedly reduced tight junction proteins such as claudin-5 and occludin in young and old mice thus affecting BBB integrity (Zhou et al. 2014; Wang et al. 2017).

Trimetazidine (TMZ) is a cytoprotective anti-ischemic drug widely used in the treatment of coronary artery disease (Dézsi 2016). It is a selective inhibitor of long‐chain 3‐ketoacyl coenzyme A thiolase; an enzyme which catalyzes the final step in β-oxidation, thus shifting energy production from free fatty acids oxidation towards glucose oxidation leading to suppression of oxygen demands and enhancement of myocardial efficiency (Abdel-Salam et al. 2011). Cardioprotective effects of TMZ have also been attributed to its reported antioxidant and anti-inflammatory effects (Zou et al. 2017). Besides its cardioprotective actions, the neuroprotective properties of TMZ have been getting more attention over the past years. TMZ has exhibited neuroprotective effects against focal cerebral ischaemia–reperfusion injury in rats (Dhote and Balaraman 2008) and anxiolytic effects in animal models of increased anxiety, owing to its antioxidant activity (Kolik et al. 2017). It has also been reported that treatment with TMZ ameliorated cognitive impairment in diabetic epileptic rats by hampering the inflammatory process (Mohamed et al. 2020). Importantly, TMZ was recently identified as a potential drug that may be repurposed to treat bipolar depression using a combination of transcriptomics, drug screening and in vitro as well as in vivo mechanistic studies conducted by Bortolasci et al. (2023).

Accordingly, the current study sought to investigate the potential benefit of TMZ in attenuating LPS-induced depressive-like behaviors, neuro-inflammation, apoptosis, oxidative stress and BBB dysfunction in mice. Special emphasis was set on the possible involvement of the TLR4/NF-κB and Nrf2/HO-1 pathways in the protective effects of TMZ.

Materials and Methods

Animals

Adult male Swiss albino mice weighing 22–25 g were used in the current study. They were obtained from the animal facility of the National Research Centre, Giza, Egypt and allowed to acclimate for 1 week before starting the experiment. Animals were maintained under temperature- and humidity-controlled conditions on a 12/12 light–dark cycle and provided access to food and water ad libitum. The experimental procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85–23, revised 2011) and were approved by the Ethics Committee for Animal Experimentation of Faculty of Pharmacy, Cairo University (PT3522). Efforts were made to reduce animal suffering and decrease the number of animals used.

Materials

Lipopolysaccharide (LPS) (Escherichia coli, serotype 0127: B8) was purchased from Sigma-Aldrich, USA. Trimetazidine dihydrochloride (TMZ) and escitalopram (Esc) were acquired from Servier and Multi-Apex Pharmaceutical Company, Egypt, respectively. They were all freshly prepared using physiological saline before use.

Induction of Depressive-like Behavior Model in Mice

Induction of a depressive-like behavior model was achieved by intraperitoneal injection of LPS at a dose of 500 µg/kg, every other day for 14 days, for a total of 7 injections. This study was performed in accordance with the previous investigations (Yang et al. 2018; Jiang et al. 2017; Abdel Rasheed et al. 2023; Gong et al. 2019), which showed that repeated peripheral LPS administration effectively provoked depressive-like behaviors and neuroinflammation in rodents.

Experimental Design

Mice were randomly divided into 5 groups (n = 15/group) as follows; control, TMZ, LPS, LPS + Esc, and LPS + TMZ groups (Fig. 1). Mice were treated orally with either Esc (10 mg/kg/day) (Kurhe and Mahesh 2016; Ibrahim et al. 2019) or TMZ (20 mg/kg/day) (Kolik et al. 2017; Jain et al. 2011; Engin et al. 2022) for 14 days covering the LPS administration period. Following treatments, mice were behaviorally tested using open field test (OFT) and forced swimming test (FST). After performing the behavioral tests, animals were euthanized by decapitation under anesthesia, then the whole brains were carefully collected and washed with ice-cold saline. Brains of three mice from each group were kept in 10% formalin for histopathological examination of the hippocampal region and for determination of mean intact neurons count. The hippocampi of the remaining mice were dissected out, flash frozen in liquid nitrogen and stored at − 80°C for further biochemical investigations. Six of these hippocampi were then homogenized in cold phosphate-buffered saline to prepare a 10% homogenate to be used for enzyme-linked immunosorbent assay (ELISA) tests while the remaining six were used for real-time PCR analysis.Fig. 1 Representation of the experimental design. LPS lipopolysaccharide, TMZ Trimetazidine, Esc escitalopram, OFT open field test, FST forced swimming test

Behavioral Assessment

Open Field Test

Locomotor function of the mice was evaluated using the OFT. The test was performed in a wooden box (80 × 80 × 40 cm) with red walls and a black floor. The floor of the box was divided into 16 equal squares by white lines. Each mouse was placed in the middle of the open field and left to explore for 3 min. The arena was cleaned carefully using 20% alcohol between each mouse to get rid of any remnant odors. The animal's locomotor function was assessed by recording the frequencies of ambulation and rearing which are the number of squares crossed and rearing, respectively (Ibrahim et al. 2022; Abdel Rasheed et al. 2018).

Forced Swimming Test

Forced swimming test was performed to assess the depressive-like behaviors in rodents (Liu et al. 2016). Mice were individually placed in a transparent cylinder (height: 40 cm, diameter: 30 cm) containing about 35 cm of water (25 ± 1°C) for 5 min. The total amount of time each animal remained immobile was recorded as the immobility time. The animal was considered immobile when floating motionless or making only small movements needed to keep its head above the water level (Zhang et al. 2014; Chai et al. 2019).

Histopathological Examination

Brain samples were fixed in neutral buffered formalin (10%) for 72 h. Samples were then processed in serial grades of ethanol and cleared in xylene. Afterwards, they were infiltrated and embedded into Paraplast tissue embedding media. A rotatory microtome was used to cut 5 μm-thick serial sagittal brain sections for demonstration of hippocampal regions in different samples and mounted on glass slides. Sections were then stained with hematoxylin and eosin (H&E) as a general staining method for tissue examination. Standard procedures for sample fixation and staining were carried out according to Culling (2013). Additionally, sections were stained with toluidine blue and six randomly selected non-overlapping fields from the CA3 hippocampal region of each sample were assessed to determine mean intact neurons count (Gad et al. 2022). All light microscopic examination and data were obtained using a full HD microscopic imaging system and Leica application module for tissue section analysis (Leica Microsystems GmbH, Germany).

Biochemical Assays

Enzyme-Linked Immunosorbent Assay

Hippocampal NF-κB and matrix metalloproteinase-9 (MMP-9) contents were measured using mouse ELISA kits supplied by LifeSpan Biosciences (USA) and Elabscience (China), respectively. Moreover, mouse MyBioSource ELISA kits (USA) were used for the assessment of TNF-α, Nrf2, HO-1, GSH, and claudin-5 contents in the hippocampus, while IL-1β and caspase 3 contents were estimated using R&D systems mouse ELISA kits (USA). The procedures were performed following the protocols provided by the manufacturers. Protein content was determined using the method described by Lowry et al. (1951).

Quantitative Real-Time PCR Analysis

Total RNA was extracted from the mice hippocampi using SV total RNA isolation system (Promega, USA) and purity of the obtained RNA was detected spectrophotometrically at 260/280 nm. Using the Reverse Transcription System (Promega, USA), the extracted RNA was reverse transcribed into complementary DNA. To evaluate gene expression of TLR4 and serotonin transporter (SERT), quantitative real-time PCR was performed using the SYBR Green JumpStart Taq ReadyMix (Sigma-Aldrich, USA) as per the manufacturer's instructions. The used primers' sequences are illustrated in Table 1. The relative expression of the target genes was estimated using the 2−∆∆CT formula (Livak and Schmittgen 2001) with β-actin used as a housekeeping gene.Table 1 Sequences of the primers used for quantitative real time-PCR analysis

Gene	
Primer sequence	
TLR4	
Forward: 5′-ATGCATGGATCAGAAACTCAGCAA-3′	
Reverse: 5′- AAACTTCCTGGGGAAAAACTCTGG-3′	
SERT	
Forward: 5′-AAGCCCCACCTTGACTCCTCC-3′	
Reverse: 5′-CTCCTTCCTCTCCTCACATATCC-3′	
β-actin	
Forward: 5′-CACTGTCGAGTCGCGTCC-3′	
Reverse: 5′-CGCAGCGATATCGTCATCCA-3′	

Statistical Analysis

Data sets that met the requirements for parametric criteria were analyzed using one-way ANOVA followed by Tukey’s multiple comparisons test. Results were presented as mean ± SD. Statistical analysis was performed using GraphPad Prism software, version 9 (GraphPad Software Inc., USA) with the significance level fixed at P < 0.05. For each effect, the F-value (F), the degree of freedom, and the statistical significance (p) were reported, moreover, pairwise comparisons were provided in each corresponding figure.

Results

The results displayed by TMZ group were presented herein concurrently with the other experimental groups. They were insignificantly different as compared to those of the control group upon histological, behavioral, and biochemical investigations. Thus, comparisons were done as related to the control group.

Trimetazidine Alleviated LPS-Induced Depressive-like Behavior in Forced Swimming Test whereas it Exerted Null Effect on Locomotor Activity in Open Field Test

LPS injection in mice instigated depressive-like symptoms which were investigated behaviorally using the FST. In comparison with the control group, LPS-injected mice showed a state of despair in FST where they displayed a marked rise in the time of immobility by 2.1-folds (F(4, 70) = 16.33, p < 0.0001). Treatment with either Esc or TMZ ameliorated LPS-induced depressive-like behavior restoring the values of immobility time to the normal range. As compared to the LPS group, Esc- or TMZ-treated mice exhibited reduced immobility duration by 51 and 45%, respectively (Fig. 2A).Fig. 2 Trimetazidine alleviated LPS-induced behavioral changes in forced swimming and open field tests. (A) Immobility time, (B) Ambulation frequency, and (C) Rearing frequency. Data were expressed as mean ± SD (n = 15) using one-way ANOVA followed by Tukey's post-hoc test, P < 0.05. LPS lipopolysaccharide, TMZ Trimetazidine, Esc escitalopram

In the open field test, the ambulation and rearing frequencies were documented to evaluate the impact of LPS, TMZ, or Esc on spontaneous locomotor activity of rats. There was insignificant variation among the experimental groups in either the frequency of ambulation (F(4, 70) = 2.658, p = 0.0398) or rearing (F(4, 70) = 1.528, p = 0.2035). These findings rule out the possibility that the depressive-like anomalies detected herein can be attributed to changes in locomotor function (Figs. 2B and C).

Trimetazidine Alleviated LPS-Induced Hippocampal Histopathological Changes in Mice

Representative photomicrographs of the H&E-stained samples of different groups were microscopically examined, in addition to using toluidine-blue stain for determining the intact neurons count in CA3 hippocampal area. The control group showed normal histological appearance of the hippocampal layers along with many records of apparent intact pyramidal neurons having well recognized nuclear and cytoplasmic details (black arrows), in addition to an intact brain matrix with the absence of cellular infiltrates. Similarly, the hippocampal sections of the TMZ group presented comparable histopathological appearance with that of the control group without recording any abnormal changes. In contrast, the histological examination of LPS group samples showed obvious dispersed neuronal degeneration as indicated by ample of damaged or necrotic neurons having pyknotic perikarya missing its subcellular details, along with mild perineuronal edema (red arrows) in contrast to reduced scattered records of intact cells (black arrows). Additionally, LPS group samples demonstrated a remarkable increase in reactive microglial cell infiltrates (arrowhead). Upon examining the toluidine blue-stained sections, LPS group presented a noticeable decline in the intact neurons mean count by 96% as compared to the control group (F(4, 25) = 382.8, p < 0.0001). Notably, treatment with either Esc or TMZ afforded equivalent neuroprotective efficacy against LPS-induced histopathological changes. The brain samples of Esc-or TMZ-treated mice exhibited few sporadic records of damaged neurons (red arrow) and higher records of apparent intact neurons (black arrow) with intact intercellular brain matrix and minimal infiltrates (arrowhead), as compared to the LPS group (Figs. 3 and 4).Fig. 3 Trimetazidine alleviated LPS-induced hippocampal histopathological changes in mice. Representative H&E photomicrographs of all experimental groups (n = 3); Control, TMZ, LPS, LPS + Esc, and LPS + TMZ groups. Magnifications: × 400. Black arrows indicate intact neurons while red arrows represent degenerated ones. Arrowheads show reactive glial cells infiltrate. LPS lipopolysaccharide, TMZ Trimetazidine, Esc escitalopram

Fig. 4 Trimetazidine enhanced hippocampal neuronal survival in LPS-injected mice. Illustrative toluidine blue-stained photomicrographs of all experimental groups; Control, TMZ, LPS, LPS + Esc, and LPS + TMZ groups. Magnifications: × 400. Black arrows represent intact neurons while red arrows show degenerated ones. A bar chart showing the mean count of intact neurons in each group; where each bar with a vertical line illustrating the mean ± SD (n = 6), using one-way ANOVA followed by Tukey's post-hoc test, P < 0.05. LPS lipopolysaccharide, TMZ Trimetazidine, Esc escitalopram

Trimetazidine Mitigated LPS-Induced Activation of Hippocampal TLR4/NF-κB Pathway

The LPS injection led to a profound activation of TLR4/NF-κB pathway as evidenced by producing a considerable increase in the hippocampal gene expression of TLR4 by 8-folds, with subsequent increment in the hippocampal content of NF-κBp65 by 1.8-folds, as compared to the control group (for TLR4: F(4, 25) = 112.8, p < 0.0001; for NF-κBp65: F(4, 25) = 98.69, p < 0.0001). Upon treating the LPS-exposed mice with TMZ, a marked drop in TLR4 gene level as well as NF-κBp65 content by 66 and 34%, respectively, was detected producing an equivalent effect with that displayed by the LPS + Esc group (Fig. 5).Fig. 5 Trimetazidine mitigated LPS-induced alterations in the hippocampal (A) TLR4 gene expression and (B) NF-κBp65 content. Data were expressed as mean ± SD (n = 6), using one-way ANOVA followed by Tukey's post-hoc test, P < 0.05. LPS lipopolysaccharide, TMZ Trimetazidine, Esc escitalopram. TLR4 Toll-like receptor-4, NF-κB nuclear factor-kappa B

Trimetazidine Reduced LPS-Induced Neuro-Inflammation, Apoptosis and Oxidative Stress

The LPS depression model was accompanied by aggravated responses of neuro-inflammation, apoptosis, and oxidative stress. In comparison to the control group, LPS-injected mice showed a profound rise in the hippocampal contents of inflammatory markers, TNF-α (4.2-folds) and IL-1β (3.9-folds), along with a significant increment in the proapoptotic caspase-3 concentration by 6.1-folds (F(4, 25) = 137.0, 318.4, and 119.9, respectively, p < 0.0001). On the contrary, they showed a considerable decrease in the antioxidant variables; namely Nrf2, HO-1, and GSH levels by 68, 70, and 50%, respectively, in comparison to their control counterparts (F(4, 25) = 256.3, 94.84, and 204.8, respectively, p < 0.0001). Treatment of LPS-injected mice with TMZ exerted neuroprotective effects leading to about 54% depression in TNF-α and IL-1β concentration along with marked decline in caspase-3 content (66%). Additionally, TMZ mitigated LPS-induced oxidative stress producing significant rise in Nrf2 (2.5-folds), HO-1 (2.6-folds), and GSH levels (1.7-folds). Such effects of TMZ on the previously mentioned markers were almost comparable with those displayed by Esc treatment except for Nrf2 where Esc outweighed the TMZ effect producing 10% increase in Nrf2 content as compared to the TMZ-treated group (Fig. 6).Fig. 6 Trimetazidine reduced LPS-induced alterations in the hippocampal contents of (A) TNF-α, (B) IL-1β, (C) Caspase-3, (D) Nrf2, (E) HO-1, and (F) GSH. Data were expressed as mean ± SD (n = 6), using one-way ANOVA followed by Tukey's post-hoc test, P < 0.05. LPS lipopolysaccharide, TMZ Trimetazidine, Esc escitalopram, TNF-α tumor necrosis factor-α, IL-1β interleukin-1β, Nrf2 nuclear factor erythroid 2–related factor 2, HO-1 heme oxygenase-1, GSH reduced glutathione

Trimetazidine Diminished LPS-Induced Surge in Hippocampal SERT Expression

The administration of LPS in mice notably augmented the hippocampal mRNA expression of SERT by 4.3-folds, in comparison to the control group (F(4, 25) = 124, p < 0.0001). This effect was inhibited by the TMZ administration where LPS + TMZ group mice showed a noticeable reduction in SERT gene level by 53%, as compared to the LPS group. Likewise, Esc administration obviously decreased the SERT gene level by 60%, as compared to the LPS group. Results afforded by the LPS + Esc and LPS + TMZ groups on SERT expression in the hippocampi were almost comparable where no substantial change was revealed between the two groups (Fig. 7).Fig. 7 Trimetazidine diminished LPS-induced changes in the hippocampal SERT gene expression. Data were expressed as mean ± SD (n = 6) using one-way ANOVA followed by Tukey's post-hoc test, P < 0.05. LPS lipopolysaccharide, TMZ Trimetazidine, Esc escitalopram, SERT serotonin transporter

Trimetazidine Attenuated LPS-Induced Blood-Hippocampus Barrier Dysregulation

The LPS administration has a detrimental effect on BBB integrity and function. LPS-injected mice displayed 2.4-folds elevation in the hippocampal content of MMP-9, an important protein involved in maintaining BBB integrity and function (F(4, 25) = 122.4, p < 0.0001). This was associated with dysregulation in BBB tight junctional proteins as exemplified by showing a considerable depression in the hippocampal content of claudin-5 (67%) leading to BBB dysfunction (F(4, 25) = 146.9, p < 0.0001). Such effects were hindered by the TMZ treatment which led to MMP-9 downregulation by 47%, while it enhanced the claudin-5 concentration in the hippocampi by 2.3-folds. These effects were almost analogous to that obtained by LPS-injected mice treated with Esc which reduced MMP-9 by 38%, while elevated claudin-5 level by 2.5-folds, as compared to the LPS group (Fig. 8).Fig. 8 Trimetazidine attenuated LPS-induced changes in the hippocampal contents of (A) MMP-9 and (B) Claudin-5. Data were expressed as mean ± SD (n = 6) using one-way ANOVA followed by Tukey's post-hoc test, P < 0.05. LPS lipopolysaccharide, TMZ Trimetazidine, Esc escitalopram, MMP-9 matrix metallopeptidase 9

Discussion

The current study investigated the antidepressant effect of TMZ; an anti-ischemic drug used for coronary artery disease, in LPS-induced depressive behaviors in mice. TMZ diminished LPS-associated oxidative stress, neuro-inflammation, and apoptosis in addition to restoration of serotonin levels via down regulation of SERT. The neuroprotective effects exerted by TMZ can be attributed to its modulatory effects on TLR4/NF-κB and Nrf2/HO-1 pathways which enforced BBB integrity and reduced despair behavior recorded by FST.

Treatment with TMZ alleviated LPS–induced animals’ despair witnessed in FST as reflected by significant decrement in the immobility time. Interestingly, TMZ-associated mood enhancement was analogous to the standard antidepressant used; Esc. Regarding the locomotor activity and rearing frequency detected by OFT, there was no significant difference among the experimental groups. Similarly, administration of LPS every other day for 2 weeks was formerly linked to increased immobility time in FST reflecting animals' despair. Meanwhile, LPS injection didn't alter the animals' spontaneous locomotor activity and rearing frequency recorded during OFT (Stupp et al. 2018; Abdel Rasheed et al. 2023). Conversely, injection of LPS was reported to induce a significant decrease in locomotor activity recorded in OFT (Mustapha et al. 2022). This contradiction could be attributed to LPS different dose regimens and mice species used which are linked to LPS-associated locomotor derangements (Yin et al. 2023). Moreover, some evidence stated that LPS-induced decrement in locomotor activity was attributed to the sickness behavior associated with LPS, yet this effect is transient as it soon develops tolerance (Lim et al. 2020a; Kahn et al. 2012).

Administration of TMZ attenuated LPS–induced neuro-inflammation with prominent inhibition of NF-κBp65 leading to an obvious decline of TNF-α and IL-1β levels owing to TLR4 downregulation. TMZ-induced anti-inflammatory effects were equivalent to the reputable antidepressant drug; Esc. Accordingly, LPS-induced stimulation of TLR4 was reported to promote the recruitment of inflammatory cells which is implicated in NF-κBp65 activation with consequent release of the formerly mentioned pro-inflammatory mediators namely; TNF-α and IL-1β (Xu et al. 2020; Qiu et al. 2021).

In the present study, inhibition of TLR4/NF-κB pathway via the administration of TMZ preserved the BBB integrity as it diminished LPS–induced neuro-inflammation leading to a significant decrease in MMP-9 content contrary to claudin-5 enhanced content. In line with the current investigation findings, activation of TLR4/NF-κB signaling is implicated in the marked disruption of BBB permeability associated with LPS injection (Hu et al. 2017). Moreover, it was reported that LPS is implicated in MMP-9 induction via NF-κB leading to claudin-5 degeneration and BBB dysfunction (Huang et al. 2021; Yang et al. 2020).

Administration of TMZ, in the current study, reduced SERT expression and consequently induced an upsurge in serotonin which enforces TMZ antidepressant activity. TMZ–induced SERT downregulation could be attributed to its inhibitory action on TLR4/NF-κB pathway. On the other hand, LPS, probably via its well-known pro-inflammatory effects, is correlated to the observed SERT upregulation with consequent depressive behaviors (Zhu et al. 2015). Moreover, LPS–associated elevation of TNF-α and IL-1β levels owing to TLR4/NF-κB cascade activation was reported to promote rapid activation of SERT (Zhu et al. 2006).

Treatment with TMZ diminished LPS–induced triad of oxidative stress, neuro-inflammation, and apoptosis leading to augmented contents of Nrf2, HO-1, and GSH. These effects are attributed to the prominent inhibition of the culprit inflammatory cascade; TLR4/NF-κB pathway along with MMP-9 and caspase-3 dismounted levels. TMZ neuroprotective effects were equivalent to Esc regarding the formerly mentioned parameters except for Nrf2 content whose elevation in LPS + Esc group out weighted that recorded in LPS + TMZ group. Several studies stated that LPS–induced neuro-inflammation could be attributed principally to its inhibitory action on Nrf2 pathway contrary to NF-κB upregulation which is a key player in BBB dysfunction, neuro-inflammation, and apoptosis (Lim et al. 2020b; Kobayashi et al. 2016; Ren et al. 2019). Besides, Nrf2 has the potential to inhibit LPS–induced up-regulation of pro-inflammatory cytokines as well as MMP-9 which induces BBB disruption and cell death (Kobayashi et al. 2016; Mao et al. 2010). Nrf2 is also Known to regulate the expression of various antioxidant and anti-inflammatory mediators such as HO-1 in addition to the antioxidant enzymes involved in GSH synthesis (Ahmad et al. 2023).

Finally, in the present investigation, the TMZ administration attenuated LPS–induced microglial activation and neuronal damage, an effect that supports its neuroprotective effects against LPS–induced neurodegeneration owing to extravagant neuroinflammation. LPS has been formerly linked to microglial activation with prominent decline in neuronal survival especially in the hippocampal brain region (M. A., Jaya, M. Hayashida, K. Tsuchie, S. J. F., Jerin, R. Mamunur, S. Miura M. Inajaki 2022; Jung et al. 2023). Moreover, LPS has been reported to promote glial activation via the upregulation of TLR4/NF-κB signaling leading to massive release of pro-inflammatory cytokines namely; TNF-α and IL-1β (Zhao et al. 2019). In line with the present study findings, TMZ was reported to exert anti-inflammatory and cytoprotective roles in various body tissues, especially the nervous tissue (Atilgan et al. 2014).

Based on the present work results, TMZ is considered as a promising antidepressant which provides new insights into depression pathogenesis and encourages adopting novel therapeutic strategies with noticeable efficacy and fewer drawbacks than those recorded with the traditional antidepressants.

Conclusion

TMZ; a well-known anti-ischemic drug, exerted mood boosting effects in LPS-injected mice. Moreover, it was able to overcome LPS-induced vicious cycle of oxidative stress, neuro-inflammation, and apoptosis probably via its ability to fine tune NF-κBp65 and Nrf2 correlation and replenish depression-associated serotonin deficiency. TMZ also preserved BBB integrity and opposed LPS-associated despair behavior witnessed in FST. Consequently, TMZ is a prosperous candidate that needs further investigations to authenticate its antidepressant activity. Meanwhile, TMZ neuroprotective effects should be investigated in different animals, for example rats, and in various depression models to explore its antidepressant activity in several milieus in order to establish a reasonable assessment of its antidepressant potential. Finally, extrapolation of the current investigation findings to humans is mandatory to validate TMZ favorable effects in humans with emphasis on various depression aspects besides the neuro-inflammatory milieu as anxiety and cognitive dysfunction associated with the disease pathogenesis.

Limitations

Extrapolation of the present study findings to humans is necessary to confirm TMZ antidepressant effects in humans with emphasis on various depression aspects besides the neuro-inflammatory milieu. Moreover, depression is a complex disorder with plenty of symptoms such as lack of interest, anxiety, and cognitive decline which are not easily mimicked by animal models of depression. Therefore, studying TMZ antidepressant activity in humans will be a great merit.

Author Contributions

Sarah S. Mohamed, Nora O. Abdel Rasheed, Weam W. Ibrahim and Nesma A. Shiha: conceptualization. Sarah S. Mohamed: methodology. Nora O. Abdel Rasheed, Nesma A. Shiha, and Weam W. Ibrahim: data curation and writing-original draft preparation. Nora O. Abdel Rasheed, Nesma A. Shiha, Sarah S. Mohamed, and Weam W. Ibrahim: reviewing, and editing. All authors have read and agreed to the published version of the manuscript.

Funding

Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Data Availability

No datasets were generated or analysed during the current study.

Declarations

Declaration of Interest

None.

Ethics Approval

The experimental procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85–23, revised 2011) and were approved by the Ethics Committee for Animal Experimentation of Faculty of Pharmacy, Cairo University (PT3522). Efforts were made to reduce animal suffering and decrease the number of animals used.

Declaration of Generative AI and AI-assisted Technologies in the Writing process

During the preparation of this work, the authors didn’t use any AI tool or AI-assisted technologies.

Competing Interests

The authors declare no competing interests.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

Abdel Rasheed NO El Sayed NS El-Khatib AS Targeting central β2 receptors ameliorates streptozotocin-induced neuroinflammation via inhibition of glycogen synthase kinase3 pathway in mice Prog Neuropsychopharmacol Biol Psychiatry 2018 86 65 75 10.1016/j.pnpbp.2018.05.010 29782959
Abdel Rasheed NO, El Sayed NS, El-Khatib AS (2018) Targeting central β2 receptors ameliorates streptozotocin-induced neuroinflammation via inhibition of glycogen synthase kinase3 pathway in mice. Prog Neuropsychopharmacol Biol Psychiatry 86:65–75. 10.1016/j.pnpbp.2018.05.01029782959
Abdel Rasheed NO Shiha NA Mohamed SS Ibrahim WW SIRT1/PARP-1/NLRP3 cascade as a potential target for niacin neuroprotective effect in lipopolysaccharide-induced depressive-like behavior in mice Int Immunopharmacol 2023 123 110720 10.1016/j.intimp.2023.110720 37562290
Abdel Rasheed NO, Shiha NA, Mohamed SS, Ibrahim WW (2023) SIRT1/PARP-1/NLRP3 cascade as a potential target for niacin neuroprotective effect in lipopolysaccharide-induced depressive-like behavior in mice. Int Immunopharmacol 123:110720. 10.1016/j.intimp.2023.11072037562290
Abdel-Salam OME Mohammed NA Sleem AA The effects of trimetazidine on lipopolysaccharide-induced oxidative stress in mice EXCLI J 2011 10 162 172 27857673
Abdel-Salam OME, Mohammed NA, Sleem AA (2011) The effects of trimetazidine on lipopolysaccharide-induced oxidative stress in mice. EXCLI J 10:162–17227857673
Abou El-Ezz D Maher A Sallam N El-Brairy A Kenawy S Trans-cinnamaldehyde Modulates Hippocampal Nrf2 Factor and Inhibits Amyloid Beta Aggregation in LPS-Induced Neuroinflammation Mouse Model Neurochem Res 2018 43 2333 2342 10.1007/s11064-018-2656-y 30302613
Abou El-Ezz D, Maher A, Sallam N, El-Brairy A, Kenawy S (2018) Trans-cinnamaldehyde Modulates Hippocampal Nrf2 Factor and Inhibits Amyloid Beta Aggregation in LPS-Induced Neuroinflammation Mouse Model. Neurochem Res 43:2333–2342. 10.1007/s11064-018-2656-y30302613
Afridi R Suk K Neuroinflammatory Basis of Depression: Learning From Experimental Models Front Cell Neurosci 2021 15 691067 10.3389/fncel.2021.691067 34276311
Afridi R, Suk K (2021) Neuroinflammatory Basis of Depression: Learning From Experimental Models. Front Cell Neurosci 15:691067. 10.3389/fncel.2021.69106734276311
Ahmad S Shah SA Khan N Nishan U Jamila N Alotaibi A A phytoconstituent 6-aminoflavone ameliorates lipopolysaccharide-induced oxidative stress mediated synapse and memory dysfunction via p-Akt/NF-kB pathway in albino mice Open Chem 2023 21 1 20220336 10.1515/chem-2022-0336
Ahmad S, Shah SA, Khan N, Nishan U, Jamila N, Alotaibi A (2023) A phytoconstituent 6-aminoflavone ameliorates lipopolysaccharide-induced oxidative stress mediated synapse and memory dysfunction via p-Akt/NF-kB pathway in albino mice. Open Chem 21(1):20220336
Arioz BI Tastan B Tarakcioglu E Tufekci KU Olcum M Ersoy N Bagriyanik A Genc K Genc S Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway Front Immunol 2019 10 1511 10.3389/fimmu.2019.01511 31327964
Arioz BI, Tastan B, Tarakcioglu E, Tufekci KU, Olcum M, Ersoy N, Bagriyanik A, Genc K, Genc S (2019) Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway. Front Immunol 10:1511. 10.3389/fimmu.2019.0151131327964
Atilgan D Parlaktas BS Uluocak N Erdemir F Markoc F Saylan O Erkorkmaz U The effects of trimetazidine and sildenafil on bilateral cavernosal nerve injury induced oxidative damage and cavernosal fibrosis in rats Sci World J 2014 1 970363 10.1155/2014/970363
Atilgan D, Parlaktas BS, Uluocak N, Erdemir F, Markoc F, Saylan O, Erkorkmaz U (2014) The effects of trimetazidine and sildenafil on bilateral cavernosal nerve injury induced oxidative damage and cavernosal fibrosis in rats. Sci World J 1:970363. 10.1155/2014/970363
Bian H Wang G Huang J Liang L Zheng Y Wei Y Wang H Xiao L Wang H Dihydrolipoic acid protects against lipopolysaccharide-induced behavioral deficits and neuroinflammation via regulation of Nrf2/HO-1/NLRP3 signaling in rat J Neuroinflammation 2020 17 166 10.1186/s12974-020-01836-y 32450903
Bian H, Wang G, Huang J, Liang L, Zheng Y, Wei Y, Wang H, Xiao L, Wang H (2020) Dihydrolipoic acid protects against lipopolysaccharide-induced behavioral deficits and neuroinflammation via regulation of Nrf2/HO-1/NLRP3 signaling in rat. J Neuroinflammation 17:166. 10.1186/s12974-020-01836-y32450903
Bortolasci CC Kidnapillai S Spolding B Truong TTT Connor T Swinton C Panizzutti B Liu ZSJ Sanigorski A Dean OM Crowley T Richardson M Bozaoglu K Vlahos K Cowdery S Watmuff B Steyn SF Wolmarans DW Engelbrecht BJ Perry C Drummond K Pang T Jamain S Gray L McGee SL Harvey BH Kim JH Leboyer M Berk M Walder K Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression Bipolar Disord 2023 25 8 661 70 10.1111/bdi.13319 36890661
Bortolasci CC, Kidnapillai S, Spolding B, Truong TTT, Connor T, Swinton C, Panizzutti B, Liu ZSJ, Sanigorski A, Dean OM, Crowley T, Richardson M, Bozaoglu K, Vlahos K, Cowdery S, Watmuff B, Steyn SF, Wolmarans DW, Engelbrecht BJ, Perry C, Drummond K, Pang T, Jamain S, Gray L, McGee SL, Harvey BH, Kim JH, Leboyer M, Berk M, Walder K (2023) Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression. Bipolar Disord 25(8):661–70. 10.1111/bdi.1331936890661
Chai H Liu B Zhan H Li X He Z Ye J Guo Q Chen J Zhang J Li S Antidepressant Effects of Rhodomyrtone in Mice with Chronic Unpredictable Mild Stress-Induced Depression Int J Neuropsychopharmacol 2019 22 157 164 10.1093/ijnp/pyy091 30407505
Chai H, Liu B, Zhan H, Li X, He Z, Ye J, Guo Q, Chen J, Zhang J, Li S (2019) Antidepressant Effects of Rhodomyrtone in Mice with Chronic Unpredictable Mild Stress-Induced Depression. Int J Neuropsychopharmacol 22:157–164. 10.1093/ijnp/pyy09130407505
Ciesielska A Matyjek M Kwiatkowska K TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling Cell Mol Life Sci 2021 78 1233 1261 10.1007/s00018-020-03656-y 33057840
Ciesielska A, Matyjek M, Kwiatkowska K (2021) TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci 78:1233–1261. 10.1007/s00018-020-03656-y33057840
Correia AS Vale N Advancements Exploring Major Depressive Disorder: Insights on Oxidative Stress, Serotonin Metabolism, BDNF, HPA Axis Dysfunction, and Pharmacotherapy Advances International J Transl Med 2024 4 176 196 10.3390/ijtm4010010
Correia AS, Vale N (2024) Advancements Exploring Major Depressive Disorder: Insights on Oxidative Stress, Serotonin Metabolism, BDNF, HPA Axis Dysfunction, and Pharmacotherapy Advances. International J Transl Med 4:176–196. 10.3390/ijtm4010010
Correia AS Cardoso A Vale N Oxidative Stress in Depression: The Link with the Stress Response, Neuroinflammation, Serotonin Neurogenesis and Synaptic Plasticity. Antioxidants (Basel) 2023 12 470 10.3390/antiox12020470 36830028
Correia AS, Cardoso A, Vale N (2023) Oxidative Stress in Depression: The Link with the Stress Response, Neuroinflammation, Serotonin. Neurogenesis and Synaptic Plasticity. Antioxidants (Basel) 12:470. 10.3390/antiox1202047036830028
C.F.A. Culling, Handbook of Histopathological and Histochemical Techniques: Including Museum Techniques, Butterworth-Heinemann, 2013.
Daneman R Prat A The blood-brain barrier Cold Spring Harb Perspect Biol 2015 7 a020412 10.1101/cshperspect.a020412 25561720
Daneman R, Prat A (2015) The blood-brain barrier. Cold Spring Harb Perspect Biol 7:a020412. 10.1101/cshperspect.a02041225561720
Dézsi CA Trimetazidine in Practice: Review of the Clinical and Experimental Evidence Am J Ther 2016 23 e871 e879 10.1097/MJT.0000000000000180 25756467
Dézsi CA (2016) Trimetazidine in Practice: Review of the Clinical and Experimental Evidence. Am J Ther 23:e871–e879. 10.1097/MJT.000000000000018025756467
Dhote V Balaraman R Anti-oxidant activity mediated neuroprotective potential of trimetazidine on focal cerebral ischaemia-reperfusion injury in rats Clin Exp Pharmacol Physiol 2008 35 630 637 10.1111/j.1440-1681.2008.04845.x 18318745
Dhote V, Balaraman R (2008) Anti-oxidant activity mediated neuroprotective potential of trimetazidine on focal cerebral ischaemia-reperfusion injury in rats. Clin Exp Pharmacol Physiol 35:630–637. 10.1111/j.1440-1681.2008.04845.x18318745
Engin S Barut EN Yaşar YK Soysal AÇ Arıcı T Kerimoğlu G Kadıoğlu M Sezen SF Trimetazidine attenuates cyclophosphamide-induced cystitis by inhibiting TLR4-mediated NFκB signaling in mice Life Sci 2022 301 120590 10.1016/j.lfs.2022.120590 35504331
Engin S, Barut EN, Yaşar YK, Soysal AÇ, Arıcı T, Kerimoğlu G, Kadıoğlu M, Sezen SF (2022) Trimetazidine attenuates cyclophosphamide-induced cystitis by inhibiting TLR4-mediated NFκB signaling in mice. Life Sci 301:120590. 10.1016/j.lfs.2022.12059035504331
Evrensel A Ünsalver BÖ Ceylan ME Neuroinflammation, Gut-Brain Axis and Depression Psychiatry Investig 2020 17 2 8 10.30773/pi.2019.08.09 31587531
Evrensel A, Ünsalver BÖ, Ceylan ME (2020) Neuroinflammation, Gut-Brain Axis and Depression. Psychiatry Investig 17:2–8. 10.30773/pi.2019.08.0931587531
Fang S Wu Z Guo Y Zhu W Wan C Yuan N Chen J Hao W Mo X Guo X Fan L Li X Chen J Roles of microglia in adult hippocampal neurogenesis in depression and their therapeutics Front Immunol 2023 14 1193053 10.3389/fimmu.2023.1193053 37881439
Fang S, Wu Z, Guo Y, Zhu W, Wan C, Yuan N, Chen J, Hao W, Mo X, Guo X, Fan L, Li X, Chen J (2023) Roles of microglia in adult hippocampal neurogenesis in depression and their therapeutics. Front Immunol 14:1193053. 10.3389/fimmu.2023.119305337881439
Fries GR Saldana VA Finnstein J Rein T Molecular pathways of major depressive disorder converge on the synapse Mol Psychiatry 2023 28 284 297 10.1038/s41380-022-01806-1 36203007
Fries GR, Saldana VA, Finnstein J, Rein T (2023) Molecular pathways of major depressive disorder converge on the synapse. Mol Psychiatry 28:284–297. 10.1038/s41380-022-01806-136203007
Gad HA Mansour M Abbas H Malatani RT Khattab MA Elmowafy E “Plurol will not miss the boat”: A new manifesto of galantamine conveyance J Drug Deliv Sci Technol 2022 74 103516 10.1016/j.jddst.2022.103516
Gad HA, Mansour M, Abbas H, Malatani RT, Khattab MA, Elmowafy E (2022) “Plurol will not miss the boat”: A new manifesto of galantamine conveyance. J Drug Deliv Sci Technol 74:103516. 10.1016/j.jddst.2022.103516
Gastfriend BD Palecek SP Shusta EV Modeling the blood-brain barrier: Beyond the endothelial cells Curr Opin Biomed Eng 2018 5 6 12 10.1016/j.cobme.2017.11.002 29915815
Gastfriend BD, Palecek SP, Shusta EV (2018) Modeling the blood-brain barrier: Beyond the endothelial cells. Curr Opin Biomed Eng 5:6–12. 10.1016/j.cobme.2017.11.00229915815
Goldsmith DR Rapaport MH Miller BJ A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression Mol Psychiatry 2016 21 1696 1709 10.1038/mp.2016.3 26903267
Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 21:1696–1709. 10.1038/mp.2016.326903267
Gong X Hu H Qiao Y Xu P Yang M Dang R Han W Guo Y Chen D Jiang P The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling Front Pharmacol 2019 10 318 10.3389/fphar.2019.00318 31001119
Gong X, Hu H, Qiao Y, Xu P, Yang M, Dang R, Han W, Guo Y, Chen D, Jiang P (2019) The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling. Front Pharmacol 10:318. 10.3389/fphar.2019.0031831001119
Hu Y, Wang Z, Pan S, Zhang H, Fang M, Jiang H, Zhang H, Gao Z, K, Xu, Z, Li (2017) Melatonin protects against blood-brain barrier damage by inhibiting the TLR4/NF-КB signaling pathway after LPS treatment in neonatal rats. Oncotarget 8(19):31638
Huang X Hussain B Chang J Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms CNS Neurosci Ther 2021 27 36 47 10.1111/cns.13569 33381913
Huang X, Hussain B, Chang J (2021) Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms. CNS Neurosci Ther 27:36–47. 10.1111/cns.1356933381913
Ibrahim WW Abdelkader NF Ismail HM Khattab MM Escitalopram Ameliorates Cognitive Impairment in D-Galactose-Injected Ovariectomized Rats: Modulation of JNK, GSK-3β, and ERK Signalling Pathways Sci Rep 2019 9 10056 10.1038/s41598-019-46558-1 31296935
Ibrahim WW, Abdelkader NF, Ismail HM, Khattab MM (2019) Escitalopram Ameliorates Cognitive Impairment in D-Galactose-Injected Ovariectomized Rats: Modulation of JNK, GSK-3β, and ERK Signalling Pathways. Sci Rep 9:10056. 10.1038/s41598-019-46558-131296935
Ibrahim WW Sayed RH Kandil EA Wadie W Niacin mitigates blood-brain barrier tight junctional proteins dysregulation and cerebral inflammation in ketamine rat model of psychosis: Role of GPR109A receptor Prog Neuropsychopharmacol Biol Psychiatry 2022 119 110583 10.1016/j.pnpbp.2022.110583 35690118
Ibrahim WW, Sayed RH, Kandil EA, Wadie W (2022) Niacin mitigates blood-brain barrier tight junctional proteins dysregulation and cerebral inflammation in ketamine rat model of psychosis: Role of GPR109A receptor. Prog Neuropsychopharmacol Biol Psychiatry 119:110583. 10.1016/j.pnpbp.2022.11058335690118
Jain S Bharal N Khurana S Mediratta PK Sharma KK Anticonvulsant and antioxidant actions of trimetazidine in pentylenetetrazole-induced kindling model in mice Naunyn Schmiedebergs Arch Pharmacol 2011 383 385 392 10.1007/s00210-011-0606-1 21318336
Jain S, Bharal N, Khurana S, Mediratta PK, Sharma KK (2011) Anticonvulsant and antioxidant actions of trimetazidine in pentylenetetrazole-induced kindling model in mice. Naunyn Schmiedebergs Arch Pharmacol 383:385–392. 10.1007/s00210-011-0606-121318336
Jazvinšćak Jembrek M Oršolić N Karlović D Peitl V Flavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder Int J Mol Sci 2023 24 6888 10.3390/ijms24086888 37108052
Jazvinšćak Jembrek M, Oršolić N, Karlović D, Peitl V (2023) Flavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder. Int J Mol Sci 24:6888. 10.3390/ijms2408688837108052
Jiang P Guo Y Dang R Yang M Liao D Li H Sun Z Feng Q Xu P Salvianolic acid B protects against lipopolysaccharide-induced behavioral deficits and neuroinflammatory response: involvement of autophagy and NLRP3 inflammasome J Neuroinflammation 2017 14 239 10.1186/s12974-017-1013-4 29212498
Jiang P, Guo Y, Dang R, Yang M, Liao D, Li H, Sun Z, Feng Q, Xu P (2017) Salvianolic acid B protects against lipopolysaccharide-induced behavioral deficits and neuroinflammatory response: involvement of autophagy and NLRP3 inflammasome. J Neuroinflammation 14:239. 10.1186/s12974-017-1013-429212498
Jung H Lee D You H Lee M Kim H Cheong E Um JW LPS induces microglial activation and GABAergic synaptic deficits in the hippocampus accompanied by prolonged cognitive impairment Sci Rep 2023 13 6547 10.1038/s41598-023-32798-9 37085584
Jung H, Lee D, You H, Lee M, Kim H, Cheong E, Um JW (2023) LPS induces microglial activation and GABAergic synaptic deficits in the hippocampus accompanied by prolonged cognitive impairment. Sci Rep 13:654737085584
Kahn MS Kranjac D Alonzo CA Haase JH Cedillos RO McLinden KA Boehm GW Chumley MJ Prolonged elevation in hippocampal Aβ and cognitive deficits following repeated endotoxin exposure in the mouse Behav Brain Res 2012 229 176 184 10.1016/j.bbr.2012.01.010 22249135
Kahn MS, Kranjac D, Alonzo CA, Haase JH, Cedillos RO, McLinden KA, Boehm GW, Chumley MJ (2012) Prolonged elevation in hippocampal Aβ and cognitive deficits following repeated endotoxin exposure in the mouse. Behav Brain Res 229:176–18422249135
M. Kamran, F. Bibi, Asim. ur. Rehman, D.W. Morris 2022 Major Depressive Disorder: Existing Hypotheses about Pathophysiological Mechanisms and New Genetic Findings. Genes 13 646 10.3390/genes13040646
Kobayashi EH Suzuki T Funayama R Nagashima T Hayashi M Sekine H Tanaka N Moriguchi T Motohashi H Nakayama K Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription Nat Commun 2016 7 1 11624 10.1038/ncomms11624 27211851
Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Hayashi M, Sekine H, Tanaka N, Moriguchi T, Motohashi H, Nakayama K (2016) Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat Commun 7(1):1162427211851
Kolik LG Nadorova AV Stolyaruk VN Miroshkina IA Tsorin IB Kryzhanovskii SA Anxiolytic Properties of Trimetazidine in Experimental Models of Increased Anxiety Bull Exp Biol Med 2017 162 643 646 10.1007/s10517-017-3677-2 28361425
Kolik LG, Nadorova AV, Stolyaruk VN, Miroshkina IA, Tsorin IB, Kryzhanovskii SA (2017) Anxiolytic Properties of Trimetazidine in Experimental Models of Increased Anxiety. Bull Exp Biol Med 162:643–646. 10.1007/s10517-017-3677-228361425
Kouba BR de Araujo Borba L Borges de Souza P Gil-Mohapel J Rodrigues ALS Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets Cells 2024 13 5 423 10.3390/cells13050423 38474387
Kouba BR, de Araujo Borba L, Borges de Souza P, Gil-Mohapel J, Rodrigues ALS (2024) Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets. Cells 13(5):423. 10.3390/cells1305042338474387
Kurhe Y Mahesh R Pioglitazone, a PPARγ agonist rescues depression associated with obesity using chronic unpredictable mild stress model in experimental mice Neurobiol Stress 2016 3 114 121 10.1016/j.ynstr.2016.05.001 27981184
Kurhe Y, Mahesh R (2016) Pioglitazone, a PPARγ agonist rescues depression associated with obesity using chronic unpredictable mild stress model in experimental mice. Neurobiol Stress 3:114–121. 10.1016/j.ynstr.2016.05.00127981184
Lee S Jeong J Kwak Y Park SK Depression research: where are we now? Mol Brain 2010 3 8 10.1186/1756-6606-3-8 20219105
Lee S, Jeong J, Kwak Y, Park SK (2010) Depression research: where are we now? Mol Brain 3:8. 10.1186/1756-6606-3-820219105
Li Z Ruan M Chen J Fang Y Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications Neurosci Bull 2021 37 863 880 10.1007/s12264-021-00638-3 33582959
Li Z, Ruan M, Chen J, Fang Y (2021) Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications. Neurosci Bull 37:863–880. 10.1007/s12264-021-00638-333582959
Lim DW Choi HJ Park SD Kim H Yu GR Kim JE Park WH Activation of the Nrf2/HO-1 pathway by Amomum villosum extract suppresses LPS-induced oxidative stress in vitro and ex vivo Evid-Based Complementary and Altern Med 2020 3 2837853 10.1155/2020/2837853
Lim DW, Choi HJ, Park SD, Kim H, Yu GR, Kim JE, Park WH (2020) Activation of the Nrf2/HO-1 pathway by Amomum villosum extract suppresses LPS-induced oxidative stress in vitro and ex vivo. Evid-Based Complementary and Altern Med 3:2837853. 10.1155/2020/2837853
DW Lim, J Park, D Han, J Lee, YT Kim, C Lee, Anti-Inflammatory Effects of Asian Fawn Lily (Erythronium japonicum) Extract on Lipopolysaccharide-Induced Depressive-Like Behavior in Mice. Nutrients 12(12) 3809
Liu L Zhang Q Cai Y Sun D He X Wang L Yu D Li X Xiong X Xu H Yang Q Fan X Resveratrol counteracts lipopolysaccharide-induced depressive-like behaviors via enhanced hippocampal neurogenesis Oncotarget 2016 7 56045 56059 10.18632/oncotarget.11178 27517628
Liu L, Zhang Q, Cai Y, Sun D, He X, Wang L, Yu D, Li X, Xiong X, Xu H, Yang Q, Fan X (2016) Resveratrol counteracts lipopolysaccharide-induced depressive-like behaviors via enhanced hippocampal neurogenesis. Oncotarget 7:56045–56059. 10.18632/oncotarget.1117827517628
Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25:402–408. 10.1006/meth.2001.126211846609
Lowry OH Rosebrough NJ Farr AL Randall RJ Protein measurement with the Folin phenol reagent J Biol Chem 1951 193 265 275 10.1016/S0021-9258(19)52451-6 14907713
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–27514907713
Ma Jaya Hayashida M Tsuchie K Jerin SJ Mamunur R Miura S Nagahama M Otsuki K Hashioka S Wake R Miyaoka T Effect of ninjin’yoeito on lipopolysaccharide-induced depressive-like behavior and glial activation in the hippocampus Shimane J Med Sci 2022 39 1 1 13
Ma Jaya, Hayashida M, Tsuchie K, Jerin SJ, Mamunur R, Miura S, Nagahama M, Otsuki K, Hashioka S, Wake R, Miyaoka T (2022) Effect of ninjin’yoeito on lipopolysaccharide-induced depressive-like behavior and glial activation in the hippocampus. Shimane J Med Sci 39(1):1–13
Maffioletti E Minelli A Tardito D Gennarelli M Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments Genes 2020 11 9 1089 10.3390/genes11091089 32961910
Maffioletti E, Minelli A, Tardito D, Gennarelli M (2020) Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments. Genes 11(9):1089. 10.3390/genes1109108932961910
Mao L Wang H Qiao L Wang X Disruption of Nrf2 Enhances the Upregulation of Nuclear Factor-kappaB Activity, Tumor Necrosis Factor-α, and Matrix Metalloproteinase-9 after Spinal Cord Injury in Mice Mediators of inflammation 2010 2010 238321 10.1155/2010/238321 20862369
Mao L, Wang H, Qiao L, Wang X (2010) Disruption of Nrf2 Enhances the Upregulation of Nuclear Factor-kappaB Activity, Tumor Necrosis Factor-α, and Matrix Metalloproteinase-9 after Spinal Cord Injury in Mice. Mediators of inflammation 2010:238321. 10.1155/2010/23832120862369
Menard C Pfau ML Hodes GE Kana V Wang VX Bouchard S Takahashi A Flanigan ME Aleyasin H LeClair KB Janssen WG Labonté B Parise EM Lorsch ZS Golden SA Heshmati M Tamminga C Turecki G Campbell M Fayad ZA Tang CY Merad M Russo SJ Social stress induces neurovascular pathology promoting depression Nat Neurosci 2017 20 1752 1760 10.1038/s41593-017-0010-3 29184215
Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, Takahashi A, Flanigan ME, Aleyasin H, LeClair KB, Janssen WG, Labonté B, Parise EM, Lorsch ZS, Golden SA, Heshmati M, Tamminga C, Turecki G, Campbell M, Fayad ZA, Tang CY, Merad M, Russo SJ (2017) Social stress induces neurovascular pathology promoting depression. Nat Neurosci 20:1752–1760. 10.1038/s41593-017-0010-329184215
Mohamed MAE Abdel-Rahman RF Mahmoud SS Khattab MM Safar MM Metformin and trimetazidine ameliorate diabetes-induced cognitive impediment in status epileptic rats Epilepsy Behav 2020 104 106893 10.1016/j.yebeh.2019.106893 32000097
Mohamed MAE, Abdel-Rahman RF, Mahmoud SS, Khattab MM, Safar MM (2020) Metformin and trimetazidine ameliorate diabetes-induced cognitive impediment in status epileptic rats. Epilepsy Behav 104:106893. 10.1016/j.yebeh.2019.10689332000097
Mustapha S, Magaji RA, Magajic M, Gayab IB, Yusha’ub Y, Chiroma SM (2022) Rutin ameliorates lipopolysaccharide-induced depressive-like behaviours in mice model via inhibition of neuroinflammation. J Afr Assoc Physiol Sci 10(1):67–77
Nonoguchi HA Kouo TWS Kortagere S Hillman J Boyle DL Mandyam CD Lipopolysaccharide Exposure Differentially Alters Plasma and Brain Inflammatory Markers in Adult Male and Female Rats Brain Sci 2022 12 972 10.3390/brainsci12080972 35892413
Nonoguchi HA, Kouo TWS, Kortagere S, Hillman J, Boyle DL, Mandyam CD (2022) Lipopolysaccharide Exposure Differentially Alters Plasma and Brain Inflammatory Markers in Adult Male and Female Rats. Brain Sci 12:972. 10.3390/brainsci1208097235892413
Owen BM Eccleston D Ferrier IN Young AH Raised levels of plasma interleukin-1beta in major and postviral depression Acta Psychiatr Scand 2001 103 226 228 10.1034/j.1600-0447.2001.00162.x 11240580
Owen BM, Eccleston D, Ferrier IN, Young AH (2001) Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand 103:226–228. 10.1034/j.1600-0447.2001.00162.x11240580
Pizzino G Irrera N Cucinotta M Pallio G Mannino F Arcoraci V Squadrito F Altavilla D Bitto A Oxidative Stress: Harms and Benefits for Human Health Oxid Med Cell Longev 2017 2017 8416763 10.1155/2017/8416763 28819546
Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, Squadrito F, Altavilla D, Bitto A (2017) Oxidative Stress: Harms and Benefits for Human Health. Oxid Med Cell Longev 2017:8416763. 10.1155/2017/841676328819546
Qiu X Wu G Wang L Tan Y Song Z Lactobacillus delbrueckii alleviates depression-like behavior through inhibiting toll-like receptor 4 (TLR4) signaling in mice Ann Transl Med 2021 9 5 366 10.21037/atm-20-4411 33842587
Qiu X, Wu G, Wang L, Tan Y, Song Z (2021) Lactobacillus delbrueckii alleviates depression-like behavior through inhibiting toll-like receptor 4 (TLR4) signaling in mice. Ann Transl Med 9(5):36633842587
Raison CL Capuron L Miller AH Cytokines sing the blues: inflammation and the pathogenesis of depression Trends Immunol 2006 27 24 31 10.1016/j.it.2005.11.006 16316783
Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27:24–31. 10.1016/j.it.2005.11.00616316783
Ren J Li L Wang Y Zhai J Chen G Hu K Gambogic acid induces heme oxygenase-1 through Nrf2 signaling pathway and inhibits NF-КB and MAPK activation to reduce inflammation in LPS-activated RAW264. 7 cells Biomed Pharmacother 2019 109 555 562 10.1016/j.biopha.2018.10.112
Ren J, Li L, Wang Y, Zhai J, Chen G, Hu K (2019) Gambogic acid induces heme oxygenase-1 through Nrf2 signaling pathway and inhibits NF-КB and MAPK activation to reduce inflammation in LPS-activated RAW264. 7 cells. Biomed Pharmacother 109:555–562
I.J.V. Stupp, E.B. Fraga-Junior, D.L. Doneda, E.H. Taniguti, Y.S. Ferreira, B.S. Dal Berto, C.B. de Lima, C.H. Rocha-Junior, E. de Lima, F.R. Santos, Z. da S. Buss, S. Vandresen-Filho, Rosiglitazone attenuates lipopolysaccharide-induced depressive-like behavior and cognitive deficits in mice. J Clin Mol Med 1(4) 1-2 10.15761/JCMM.1000123
Taniguti EH Ferreira YS Stupp IJV Fraga-Junior EB Mendonça CB Rossi FL Ynoue HN Doneda DL Lopes L Lima E Buss ZS Vandresen-Filho S Neuroprotective effect of melatonin against lipopolysaccharide-induced depressive-like behavior in mice Physiol Behav 2018 188 270 275 10.1016/j.physbeh.2018.02.034 29458118
Taniguti EH, Ferreira YS, Stupp IJV, Fraga-Junior EB, Mendonça CB, Rossi FL, Ynoue HN, Doneda DL, Lopes L, Lima E, Buss ZS, Vandresen-Filho S (2018) Neuroprotective effect of melatonin against lipopolysaccharide-induced depressive-like behavior in mice. Physiol Behav 188:270–275. 10.1016/j.physbeh.2018.02.03429458118
Wang X Xue G-X Liu W-C Shu H Wang M Sun Y Liu X Sun YE Liu C-F Liu J Liu W Jin X Melatonin alleviates lipopolysaccharide-compromised integrity of blood-brain barrier through activating AMP-activated protein kinase in old mice Aging Cell 2017 16 414 421 10.1111/acel.12572 28156052
Wang X, Xue G-X, Liu W-C, Shu H, Wang M, Sun Y, Liu X, Sun YE, Liu C-F, Liu J, Liu W, Jin X (2017) Melatonin alleviates lipopolysaccharide-compromised integrity of blood-brain barrier through activating AMP-activated protein kinase in old mice. Aging Cell 16:414–421. 10.1111/acel.1257228156052
Wei Y Hu Y Qi K Li Y Chen J Wang R Dihydromyricetin improves LPS-induced sickness and depressive-like behaviors in mice by inhibiting the TLR4/Akt/HIF1a/NLRP3 pathway Behavioural Brain Research 2022 423 113775 10.1016/j.bbr.2022.113775 35101458
Wei Y, Hu Y, Qi K, Li Y, Chen J, Wang R (2022) Dihydromyricetin improves LPS-induced sickness and depressive-like behaviors in mice by inhibiting the TLR4/Akt/HIF1a/NLRP3 pathway. Behavioural Brain Research 423:113775. 10.1016/j.bbr.2022.11377535101458
World Health Organization, Depression, (2023). https://www.who.int/news-room/fact-sheets/detail/depression (accessed October 7, 2023).
Xu X, Piao HN, Aosai F, Zeng XY, Cheng JH, Cui YX, Li J, J, MA, HR, Piao, X, Jin (2020) Arctigenin protects against depression by inhibiting microglial activation and neuroinflammation via HMGB1/TLR4/NF-КB and TNF-α/TNFR1/NF-КB pathways. Br J Pharmacol 177(22):5224–5245
Yang M Dang R Xu P Guo Y Han W Liao D Jiang P Dl-3-n-Butylphthalide improves lipopolysaccharide-induced depressive-like behavior in rats: involvement of Nrf2 and NF-κB pathways Psychopharmacology 2018 235 2573 2585 10.1007/s00213-018-4949-x 29943092
Yang M, Dang R, Xu P, Guo Y, Han W, Liao D, Jiang P (2018) Dl-3-n-Butylphthalide improves lipopolysaccharide-induced depressive-like behavior in rats: involvement of Nrf2 and NF-κB pathways. Psychopharmacology 235:2573–2585. 10.1007/s00213-018-4949-x29943092
C.C. Yang, L.D. Hsiao, H.C. Tseng, C.M. Kuo, C.M. Yang, 2020 Pristimerin inhibits MMP-9 expression and cell migration through attenuating NOX/ROS-dependent NF-КB activation in rat brain astrocytes challenged with LPS. J Inflamm Res 325–341
Yin R Zhang K Li Y Tang Z Zheng R Ma Y Xie Y Lipopolysaccharide-induced depression-like model in mice: meta-analysis and systematic evaluation Front Immunol 2023 14 1181973 10.3389/fimmu.2023.1181973 37359525
Yin R, Zhang K, Li Y, Tang Z, Zheng R, Ma Y, Xie Y (2023) Lipopolysaccharide-induced depression-like model in mice: meta-analysis and systematic evaluation. Front Immunol 14:118197337359525
Yu H Kan J Tang M Zhu Y Hu B Lipopolysaccharide Preconditioning Restricts Microglial Overactivation and Alleviates Inflammation-Induced Depressive-like Behavior in Mice Brain Sci 2023 13 549 10.3390/brainsci13040549 37190515
Yu H, Kan J, Tang M, Zhu Y, Hu B (2023) Lipopolysaccharide Preconditioning Restricts Microglial Overactivation and Alleviates Inflammation-Induced Depressive-like Behavior in Mice. Brain Sci 13:549. 10.3390/brainsci1304054937190515
Zhang Y Liu L Peng YL Liu YZ Wu TY Shen XL Zhou JR Sun DY Huang AJ Wang X Wang YX Jiang CL Involvement of inflammasome activation in lipopolysaccharide-induced mice depressive-like behaviors CNS Neurosci Ther 2014 20 119 124 10.1111/cns.12170 24279434
Zhang Y, Liu L, Peng YL, Liu YZ, Wu TY, Shen XL, Zhou JR, Sun DY, Huang AJ, Wang X, Wang YX, Jiang CL (2014) Involvement of inflammasome activation in lipopolysaccharide-induced mice depressive-like behaviors. CNS Neurosci Ther 20:119–124. 10.1111/cns.1217024279434
Zhang B Wang PP Hu KL Li LN Yu X Lu Y Chang HS Antidepressant-Like Effect and Mechanism of Action of Honokiol on the Mouse Lipopolysaccharide (LPS) Depression Model Molecules 2019 24 2305 10.3390/molecules24112035 31234368
Zhang B, Wang PP, Hu KL, Li LN, Yu X, Lu Y, Chang HS (2019) Antidepressant-Like Effect and Mechanism of Action of Honokiol on the Mouse Lipopolysaccharide (LPS) Depression Model. Molecules 24:2305. 10.3390/molecules2411203531234368
Zhao J Bi W Xiao S Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice Sci Rep 2019 9 5790 10.1038/s41598-019-42286-8 30962497
Zhao J, Bi W, Xiao S et al (2019) Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci Rep 9:5790. 10.1038/s41598-019-42286-830962497
Zhou T Zhao L Zhan R He Q Tong Y Tian X Wang H Zhang T Fu Y Sun Y Xu F Guo X Fan D Han H Chui D Blood-brain barrier dysfunction in mice induced by lipopolysaccharide is attenuated by dapsone Biochem Biophys Res Commun 2014 453 419 424 10.1016/j.bbrc.2014.09.093 25268765
Zhou T, Zhao L, Zhan R, He Q, Tong Y, Tian X, Wang H, Zhang T, Fu Y, Sun Y, Xu F, Guo X, Fan D, Han H, Chui D (2014) Blood-brain barrier dysfunction in mice induced by lipopolysaccharide is attenuated by dapsone. Biochem Biophys Res Commun 453:419–424. 10.1016/j.bbrc.2014.09.09325268765
Zhu CB Blakely RD Hewlett WA The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters Neuropsychopharmacology 2006 31 10 2121 2131 10.1038/sj.npp.1301029 16452991
Zhu CB, Blakely RD, Hewlett WA (2006) The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31(10):2121–213116452991
Zhu L, Wei T, Gao J, Chang X, H, He, M, Miao, T, Yan (2015) Salidroside attenuates lipopolysaccharide (LPS) induced serum cytokines and depressive-like behavior in mice. Neurosci Lett 606:1–6
Zhuo R Cheng X Luo L Yang L Zhao Y Zhou Y Peng L Jin X Cui L Liu F Yang L Cinnamic Acid Improved Lipopolysaccharide-Induced Depressive-Like Behaviors by Inhibiting Neuroinflammation and Oxidative Stress in Mice Pharmacology 2022 107 281 289 10.1159/000520990 35325888
Zhuo R, Cheng X, Luo L, Yang L, Zhao Y, Zhou Y, Peng L, Jin X, Cui L, Liu F, Yang L (2022) Cinnamic Acid Improved Lipopolysaccharide-Induced Depressive-Like Behaviors by Inhibiting Neuroinflammation and Oxidative Stress in Mice. Pharmacology 107:281–289. 10.1159/00052099035325888
Zou H Zhu X-X Ding Y-H Jin Q-Y Qian L-Y Huang D-S Cen X-J Trimetazidine in conditions other than coronary disease, old drug, new tricks? Int J Cardiol 2017 234 1 6 10.1016/j.ijcard.2017.02.083 28256321
Zou H, Zhu X-X, Ding Y-H, Jin Q-Y, Qian L-Y, Huang D-S, Cen X-J (2017) Trimetazidine in conditions other than coronary disease, old drug, new tricks? Int J Cardiol 234:1–6. 10.1016/j.ijcard.2017.02.08328256321
Zuo C Cao H Song Y Gu Z Huang Y Yang Y Miao J Zhu L Chen J Jiang Y Wang F Nrf2: An all-rounder in depression Redox Biol 2022 58 102522 10.1016/j.redox.2022.102522 36335763
Zuo C, Cao H, Song Y, Gu Z, Huang Y, Yang Y, Miao J, Zhu L, Chen J, Jiang Y, Wang F (2022) Nrf2: An all-rounder in depression. Redox Biol 58:102522. 10.1016/j.redox.2022.10252236335763
